(MENAFN- Ameliorate Digital Consultancy)
According to the most recent Persistence Market Research (PMR) report, the intravitreal (ivt) injectables market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Introduction Intravitreal (IVT) injection is a technique used in ophthalmology to deliver medication directly into the eye. The medication is injected into the vitreous, the gel-like substance that fills the back of the eye, where it can target the specific area that needs treatment. This method is commonly used to treat retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. The global intravitreal (IVT) injectable market has been growing steadily in recent years and is expected to continue its growth trajectory over the coming years.
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete blindness. Intravitreal injection is a safe and easy method of treating retinal disorders.
According to the National Eye Institute (NEI), around 2.0 million people in the United States were afflicted by AMD in 2010, with the figure anticipated to more than increase to 5.4 million by 2050. To address rising demand, industry players are focused on innovation by developing a solid pipeline of IVT injections for the treatment of retinal diseases.
Request For Free Sample Report of Intravitreal (IVT) Injectable Market @
Between 2022 and 2028, North America is expected to account for a significant share of the global market. Increased incidence of age-related macular degeneration (AMD) is expected to stimulate demand for intravitreal (IVT) injectables in the United States.
Due to an increase in the elderly population and an increase in the incidence of retinal illnesses, the European market is also expected to fuel market growth. In the coming years, countries such as India and China are likely to boost demand for intravitreal (IVT) injectables in the Asia Pacific region, due to the presence of a sizable patient pool suffering from diabetes mellitus.
Companies
Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
For critical insights on this market, request for customization here@
Intravitreal (IVT) Injectable Market Categorization
Intravitreal (IVT) Injectable Market by Indication
Macular Degeneration
Diabetic Retinopathy
Retinal Vein Occlusion
Endophthalmitis
Others
Intravitreal (IVT) Injectable Market by Drug Class
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Intravitreal (IVT) Injectable Market by Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
PMR has presented a comprehensive report based on Molecular Diagnostic Reagent Market as per Material (Sample Preparation Kits, PCR Assay Kits, In situ Hybridization Kits, Microarray Kit, and Sequencing Kit), Application (Pathogen Detection, Biomarker Screening, Therapeutic Monitoring and others), End User (Hospitals, Laboratories, Research Institutes, Biopharmaceutical Companies and others) based on seven regions.
For In-Depth Competitive Analysis, Buy Now @
Related Reports:
telemedicine market
robotic surgery market
veterinary teleradiology market
dental radiology equipment market
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –